Filing Details

Accession Number:
0000899243-23-010714
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-05 16:15:08
Reporting Period:
2023-04-03
Accepted Time:
2023-04-05 16:15:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1527599 Synlogic Inc. SYBX Pharmaceutical Preparations (2834) 261824804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1914184 Vangsted Michael Jensen C/O Synlogic, Inc.
301 Binney Street, Suite 402
Cambridge MA 02142
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-04-03 2,553 $0.58 46,947 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares sold by the reporting person on April 3, 2023 to cover the tax liability in connection with the vesting of a restricted stock award, vesting on April 1, 2023, that was granted in 2022.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5750 to $0.5798, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  3. Includes 5,000 shares acquired on September 30, 2022 and 5,000 shares acquired on March 31, 2023 under the Synlogic, Inc. 2015 Employee Stock Purchase Plan.